Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
G protein-coupled receptor 157 (GPR157) is an orphan GPCR predominantly expressed in the primary cilia of radial glial progenitors (RGPs) during early cortical development, where it acts as a transducer of cerebrospinal fluid (CSF)-derived signals to promote neuronal differentiation[1][2][4]. It couples with the Gq-class of heterotrimeric G-proteins, activating the phospholipase C–IP3–Ca(2+) signaling cascade, and plays a critical role in the positive regulation of neurogenesis during corticogenesis[1][2]. Loss or knockdown of GPR157 impairs neuronal differentiation of RGPs, indicating its importance for normal brain development[1][4]. Currently, GPR157 is classified as an orphan receptor, with no endogenous ligand identified, and has been genetically associated with Schnyder corneal dystrophy[3]. No targeted drugs or well-established clinical applications have been reported for GPR157 at present.
Activation of Gq-protein signaling; Coupling to phospholipase C (PLC)–IP3–Ca(2+) pathway, leading to increased intracellular calcium
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G protein-coupled receptor 157 (GPR157).